Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The present study assesses the pharmacokinetic profile of Ivermectin (IVM) in healthy human
volunteers and aims to create a physiologically-based pharmacokinetic model. Planned
indication is the prevention of malaria transmission.